Hydra Biosciences News
Most Popular Hydra Biosciences Story
Emerging Drug Developer: Hydra Biosciences
Hydra Biosciences stakes its future on ion channels When Hydra Biosciences announced last week that it had raised $22 million in its Series D round, the developer earmarked much of that cash for
Read more...Latest Headlines
- March 2, 2009
- January 20, 2009
- January 16, 2009
- July 26, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
